-
SS Innovations International (SSII) files $150M mixed shelf
-
SS Innovations receives regulatory approvals in four countries
-
SS Innovations International (SSII) files for $50M share offering
-
SS Innovations reports preliminary Q4 2025 revenue of $15 million
-
SS Innovations completes 5-millimeter surgical instruments for pediatric care
-
SS Innovations submits FDA application for surgical robotic system
-
SS Innovations completes first telesurgery using new console system
-
SS Innovations International (SSII) Misses Q3 EPS by 2c
-
SS Innovations completes study for surgical robot FDA submission
-
SS Innovations completes pediatric telesurgery using robotic system
-
SS Innovations completes first robotic telesurgery from mobile unit
-
SS Innovations completes intercontinental robotic cardiac telesurgery
-
SS Innovations reaches 100 installations of robotic surgical system
-
SS Innovations completes robotic telesurgery for weight loss procedures
-
SS Innovations (SSII) Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company’s SSi Mantra 3 Surgical Robotic System
-
SS Innovations International (SSII) to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications
-
Scenario Systems International, Inc. (SSII) Announces CFO Change
-
Scenario Systems International, Inc. (SSII) to Uplist to Nasdaq
-
SS Innovations International (SSII) Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting

